CRISPR/Cas9-based point-of-care lateral flow biosensor with improved performance for rapid and robust detection of Mycoplasma pneumonia
Analytica Chimica Acta · 2023-05 · 1257 · 341175
DOI: 10.1016/j.aca.2023.341175 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytica Chimica Acta, 2023-05. Verfasst von Rong Zhu und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Anhui Medical University, Hefei, 230032, Anhui, PR China; The First People's Hospital of Hefei, Third Affiliated Hospital of Anhu…. Hauptthemen laut MEDLINE: Pneumonia, Mycoplasma, Biosensing Techniques. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Natural Science Foundation of Anhui Province, University Natural Science Research Project of Anhui Province.
Abstract (Originalsprache)
Screening of acute respiratory infections causes serious challenges in urgent point-of-care scenarios where conventional methods are impractical and alternative techniques suffer from low accuracy, poor robustness, and reliance on sophisticated instruments. As an improvement to this paradigm, we report a point-of-care lateral flow biosensor (LFB) based on the recognition property of clustered regularly interspaced short palindromic repeats (CRISPR)/associated protein 9 (Cas9) and apply it to the detection of Mycoplasma pneumoniae (M. pneumoniae). The designed biosensor employs CRISPR/Cas9 for secondary recognition after preamplification of target gene using specific primer set, avoiding false positives caused by nontarget factors. The high amplification efficiency and low applicable temperatures of recombinase polymerase amplification brings the detection limit of the biosensor to 3 copies even at a preamplification temperature of 25 °C. Its practical application is further demonstrated with 100% accuracy by testing with 43 M. pneumoniae-infected specimens and 80 uninfected specimens. Additionally, the entire detection, including pretreatment, preamplification, CRISPR/Cas9 recognition, and visual analysis, can be completed in 30 min. Featured with the combination of CRISPR/Cas9 and LFB, the biosensor we developed herein ensures excellent convenience, accuracy, and robustness, which endows promising point-of-care screening potential for infectious pathogens.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Pharmacy, Anhui Medical University, Hefei, 230032, Anhui, PR China; The First People's Hospital of Hefei, Third Affiliated Hospital of Anhui Medical University, Hefei, 230032, Anhui, PR China.
- Department of Nutrition and Food Hygiene, School of Public Health, Anhui Medical University, Hefei, 230032, Anhui, PR China.
- The First People's Hospital of Hefei, Third Affiliated Hospital of Anhui Medical University, Hefei, 230032, Anhui, PR China.
- School of Pharmacy, Anhui Medical University, Hefei, 230032, Anhui, PR China.
- Engineering Research Center of Bio-process, MOE, School of Food and Biological Engineering, Hefei University of Technology, Hefei, 230009, Anhui, PR China.
- School of Pharmacy, Anhui Medical University, Hefei, 230032, Anhui, PR China. Electronic address: wangjienar@163.com.
Förderung
- Natural Science Foundation of Anhui Province
- University Natural Science Research Project of Anhui Province
Zitieren
APA
Zhu, R., Jiang, H., Li, C., Li, Y., Peng, M., Wang, J., Wu, Q., Yan, C., Bo, Q., Wang, J., Shen, C., & Qin, P. (2023). CRISPR/Cas9-based point-of-care lateral flow biosensor with improved performance for rapid and robust detection of Mycoplasma pneumonia. Analytica Chimica Acta, 1257, 341175. https://doi.org/10.1016/j.aca.2023.341175
Vancouver
Zhu R, Jiang H, Li C, Li Y, Peng M, Wang J, et al. CRISPR/Cas9-based point-of-care lateral flow biosensor with improved performance for rapid and robust detection of Mycoplasma pneumonia. Analytica Chimica Acta. 2023;1257:341175. doi:10.1016/j.aca.2023.341175
BibTeX
@article{Zhu2023,
author = {Zhu, Rong and Jiang, Han and Li, Chaoyou and Li, Yan and Peng, Min and Wang, Junfeng and Wu, Qian and Yan, Chao and Bo, Qingli and Wang, Jie and Shen, Chenlin and Qin, Panzhu},
title = {CRISPR/Cas9-based point-of-care lateral flow biosensor with improved performance for rapid and robust detection of Mycoplasma pneumonia},
journal = {Analytica Chimica Acta},
year = {2023},
volume = {1257},
pages = {341175},
doi = {10.1016/j.aca.2023.341175}
}
EUVIMED